Towards the Lowest Efficacious Dose (ToLEDo): Results of a Multicenter Non ‐Inferiority Randomized Open‐Label Controlled Trial Assessing Tocilizumab or Abatacept Injection Spacing in Rheumatoid Arthritis in Remission

ConclusionsThe ToLEDo trial failed to demonstrate NI for the proposed ABA or TCZ tapering strategy.

Source: Arthritis and Rheumatology - November 9, 2023 Category: Rheumatology Authors: Joanna Kedra, Philippe Dieud é, Caroline Giboin, Hubert Marotte, Carine Salliot, Thierry Schaeverbeke, Aleth Perdriger, Martin Soubrier, Jacques Morel, Arnaud Constantin, Emmanuelle Dernis, Valérie Royant, Jean‐Hugues Salmon, Thao Pham, Tags: Full Length Source Type: research